KHK-IN-8 is a selective KHK inhibitor, with an IC 50 of 13.0 nM against hKHK-C and an IC 50 of 22.7 nM against hKHK-A . KHK-IN-8 is applicable to research on non-alcoholic steatohepatitis, type 2 diabetes and obesity.
Products | Products > Disease Areas > Type 2 Diabetes | Products > Disease Areas > Obesity | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Digestive System Inflammation | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Ketohexokinase
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。